TECH vs XNCR · P/E 65, rev $1.22B vs rev $55.7M
Bio-Techne Corp (TECH) versus Xencor Inc (XNCR) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Xencor Inc (XNCR) is a biotechnology company listed on US.
Latest reported TECH revenue for 2026-06-30 was $1.22B. Net income was $181.9M. Revenue was down 0.4% from 2025-06-30 to 2026-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported XNCR revenue for 2026-06-30 was $55.7M. Net income was -$150.6M. XNCR currently screens at market cap $664.0M.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. XNCR currently screens at market cap $664.0M.
Not investment advice. Open the TECH and XNCR stock pages for the full models.
Not investment advice.